Yes, having a clear funding plan is highly recommended, though not strictly mandatory, when submitting a Pre-Feasibility Study (PFS) to the Australian Securities Exchange (ASX). Here's why it is important:
1. Compliance with ASX Requirements
- While the ASX does not explicitly require a detailed funding plan in the PFS itself, clear financial and funding assumptions are essential for complying with the JORC Code (2012).
- The JORC Code requires disclosure of material assumptions underpinning production targets and financial forecasts.
- If the viability of the project relies on securing funding, a clear plan helps demonstrate that the company has considered how the project will be financed.
2. Market and Investor Confidence
- The absence of a clear funding plan can raise concerns among investors and the market about the feasibility of the project.
- A well-defined funding strategy reassures stakeholders that the company is taking a realistic and actionable approach to financing project development.
3. ASX Queries and Delays
- If the funding plan is vague or omitted, the ASX may request clarification or additional information, delaying the PFS announcement.
- For instance, if a project's capital expenditure (CAPEX) is high and no financing details are provided, the ASX may question how the company plans to proceed.
4. Past Examples
- Companies have faced delays or investor criticism due to unclear or overly optimistic funding assumptions. For example:
- Case A: A company announced a PFS with significant CAPEX but provided no details on potential debt or equity financing, leading to ASX queries and skepticism from investors.
- Case B: Another company addressed funding explicitly, outlining debt facilities, joint venture arrangements, or equity raises, which helped avoid delays and improve market reception.
Best Practices
To avoid issues, companies should:
- Include High-Level Funding Details: Outline whether the project will be funded through equity, debt, joint ventures, or other mechanisms.
- Provide Realistic Assumptions: Ensure assumptions around funding align with the company’s market position and financial capabilities.
- Engage Early with ASX: Discuss potential funding disclosures during the pre-lodgment stage to address any concerns upfront.
In conclusion, while a specific funding plan may not be explicitly mandatory, it is a critical component of a robust and credible PFS submission to ASX.
- Forums
- ASX - By Stock
- AAU
- Ann: Revision to Updated Scoping Study Nueva Sabana Mine, Cuba
AAU
antilles gold limited
Add to My Watchlist
20.0%
!
0.4¢

Ann: Revision to Updated Scoping Study Nueva Sabana Mine, Cuba, page-115
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $9.516M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $7.872K | 1.634M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 43843446 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 14215983 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 43596023 | 0.004 |
51 | 60906679 | 0.003 |
14 | 29424543 | 0.002 |
12 | 60314950 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 14215983 | 21 |
0.006 | 14354473 | 14 |
0.007 | 2937007 | 6 |
0.008 | 5152450 | 6 |
0.009 | 2803571 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AAU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online